20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Composition containing artesunate
#4502COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY DRIVE
#4503ORGANIC COMPOUNDS
#4504METHODS OF CREATING A SUBSTANCE WITH DIFFERENT FREEZING POINTS BY ENCAPSULATION
#4505MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINE
#4506SYSTEMS AND METHODS FOR PREPARING AND TRANSPORTING AN INJECTABLE SLURRY
#4507MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
#4508ALLOGENIC CAR-T CELL THERAPY
#4509FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY
#4510ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#4511Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disorders
#4512OXIDATION-RESISTANT SERPINS
#4513REFINING METHOD OF OPHTHALMIC PROTEIN PHARMACEUTICAL
#4514DOPAMINE RECEPTOR D1 AGONISTS AND METHODS OF USE
#4515DRUG DELIVERY DEVICE
#4516Gene Editing to Improve Joint Function
#4517FORMULATIONS OF BENDAMUSTINE
#4518Unit dose of a composition for treating cancer
#4519Sea lice vaccine
#4520COMPOSITION FOR PROMOTING GROWTH OR SUPPRESSING DECREASE OF MESENCHYMAL STEM CELLS
#4521Polynucleotides encoding interleukin-12 (IL12) and uses thereof
#4522METHODS AND COMPOSITIONS FOR TREATING ARTHRITIS
#4523USES OF DAN FAMILY BMP ANTAGONISTS FOR INHIBITING OCULAR NEOVASCULARIZATION AND TREATING OCULAR CONDITIONS
#4524ANTIMICROBIAL THERAPY THROUGH THE COMBINATION OF PORE-FORMING AGENTS AND HISTONES
#4525TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
#4526NON-VIRAL MODIFICATION OF MESENCHYMAL STEM CELLS
#4527IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#4528METHODS TO PREVENT, INHIBIT OR TREAT INTERVERTEBRAL DISC DEGENERATION
#4529Ganaxolone for use in treatment of status epilepticus
#4530Compositions and methods for preventing or treating muscle conditions
#4531Parenteral compositions comprising methylene blue
#4532COMBINATION THERAPY
#4533ANTIMICROBIAL COMPOSITIONS
#4534Autotaxin inhibitor compounds
#4535USE OF BIPOLAR TRANS CAROTENOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR TREATMENT OF CANCER
#4536Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#4537Methods of delivering a neuroprotective polypeptide to the central nervous system
#4538LIPOSOMAL DOXORUBICIN FORMULATION, METHOD FOR PRODUCING A LIPOSOMAL DOXORUBICIN FORMULATION AND USE OF A LIPOSOMAL DOXORUBICIN FORMULATION AS A MEDICAMENT
#4539PARENTERAL CARBAMAZEPINE FORMULATION
#4540Absorbent structure for absorbent articles
#4541METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#4542VECTORS AND COMPOSITIONS FOR TREATING HEMOGLOBINOPATHIES
#4543METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
#4544Formulations and methods for direct sodium removal in patients having severe renal dysfunction
#4545COMPOSITIONS AND USE OF ENGINEERED MYOGENIC CELLS
#4546BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2
#4547SSTR-TARGETED CONJUGATES AND FORMULATIONS THEREOF
#4548ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN
#4549Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer
#4550METHODS OF ADMINISTERING ANTI-SIGLEC-8 ANTIBODIES AND CORTICOSTEROIDS
#4551ENGINEERED VACCINIA VIRUS
#4552TROPICAL DISEASE VACCINES
#4553TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELL RESPONSES
#4554METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#4555BOTULINUM TOXIN TYPE A COMPLEX, AND FORMULATION THEREOF AND USAGE METHOD THEREFOR
#4556Methods and compositions for the treatment of exocrine pancreatic insufficiency
#4557USE OF DERMCIDIN IN STERILE INFLAMMATORY CONDITIONS
#4558Mixtures and formulations
#4559POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#4560POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR
#4561METHODS OF USE FOR CAR T CELLS
#4562INJECTABLE NUTRITIONAL SUPPLEMENT
#4563THERAPEUTIC RNA FOR OVARIAN CANCER
#4564METHODS OF TREATING INFECTIONS IN OVERWEIGHT AND OBESE PATIENTS USING ANTIBIOTICS
#4565METHODS AND COMPOSITIONS FOR TREATING OBESITY AND/OR DIABETES AND FOR IDENTIFYING CANDIDATE TREATMENT AGENTS
#4566CALPAIN INHIBITORS AND USES THEREOF FOR TREATING NEUROLOGICAL DISORDERS
#4567Treatment of glaucoma using endothelin receptor antagonists
#4568Microsphere-Based Injectible Celecoxib Formulation
#4569Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#4570Nanoparticles for treatment of posterior segment ocular diseases and conditions
#4571LONG-LASTING FORMULATION CONTAINING RIVASTIGMINE, AND METHOD FOR PREPARING SAME
#4572VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS
#4573APTAMER SPECIFICALLY BINDING TO CANCER STEM CELLS, AND USE THEREOF
#4574Methods and compositions for inhibiting PMP22 expression
#4575TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED FORMULATIONS AND USES THEREOF
#4576LEVODOPA POLYMERIC CONJUGATES, FORMULATIONS THEREOF, AND THEIR USES FOR THE TREATMENT OF PARKINSON'S DISEASE
#4577FORMULATION COMPRISING ANTI-CD47/PD-L1 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
#4578HYDROPHILIC LINKERS FOR MULTIVALENT PEPTIDE CONJUGATES
#4579HUMAN ANTIBODIES TO BONE MORPHOGENETIC PROTEIN 6
#4580IN VIVO TARGETING OF CELLS WITH LIGAND-CONJUGATED PARTICLES
#4581Adeno-associated virus variant capsids and methods of use thereof
#4582METHOD FOR TREATMENT OF NEUROCOGNITIVE DECLINE
#4583METHODS FOR TREATING TUMORS
#4584RNA constructs and uses thereof
#4585Phosphonate-Drug Conjugates
#4586Protection and delivery of multiple therapeutic proteins
#4587AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LYOPHILIZED FORM (VARIANTS)
#4588NUCLEIC ACID BASED COMBINATION VACCINES
#4589VECTORS AND METHODS FOR REGENERATIVE THERAPY
#4590COMPOSITION COMPRISING RECOMBINANT PARATHYROID HORMONE FOR HEALING AFTER ROTATOR CUFF REPAIR
#4591HIGH CONCENTRATION INSULIN FORMULATION
#4592CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS
#4593COMBINATION THERAPY WITH CD13-TARGETED CHIMERIC PROTEINS OR CHIMERIC PROTEIN COMPLEXES
#4594Method of Treating Peripheral Nerve Disorders
#4595C-terminal fragment of tetanus toxin (HC) for treatment of depression
#4596COMPOSITIONS AND METHODS FOR TREATING ACUTE RADIATION SYNDROME
#4597Herb medicine composition for alleviating or treating asthma, and oriental pharmacopuncture solution containing same and injection containing same
#4598NANOVESICLES FROM ADULT STEM CELLS AND ITS USE FOR TARGETED THERAPY
#4599ORGANOIDS COMPRISING ISOLATED RENAL CELLS AND USES THEREOF
#4600A COMPOSITION, A KIT AND USE THEREOF
#4601Methods to Stabilize and Reverse Atherosclerotic Lesions by Sulfated Polysaccharides
#4602COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH
#4603USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
#4604COMPOSITIONS AND METHODS FOR TREATING NONINFECTIOUS UVEITIS
#4605GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS
#4606Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
#4607USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#4608GENE THERAPY FOR MESOTHELIOMA
#4609Methods of treatment
#4610Parenteral esmolol formulation
#4611COMBINATION OF IBUPROFEN AND TRAMADOL FOR RELIEVING PAIN
#4612Methods and compositions for diagnosing and treating glaucoma
#4613PHARMACEUTICAL FORMULATIONS FOR A LIQUID DOSAGE FORM AND A CONTROLLED RELEASE DOSAGE FORM
#4614Surfactant peptide nanostructures and uses thereof in drug delivery
#4615SUSTAINED-RELEASE LIPID COMPOSITION AND PREPARATION METHOD THEREFOR
#4616Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell
#4617NEBULIZING DEVICES AND SYSTEMS HAVING BIOMETRIC DATA ACQUISITION AND MONITORING CAPABILITIES
#4618Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
#4619Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#4620Heterotandem bicyclic peptide complex
#4621AGONIST OF SPEXIN-BASED GALANIN TYPE 2 RECEPTOR AND USE THEREOF
#4622Iron compositions and methods of making and using the same
#4623Glucose level management without carbohydrate counting
#4624FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS
#4625IL-6 antagonist formulations and uses thereof
#4626VACCINE FOR THE PREVENTION OF BREAST CANCER RELAPSE
#4627COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER
#4628TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
#4629Compositions and methods for subcutaneous administration of cancer immunotherapy
#4630ABCB5+ STEM CELL THERAPEUTICS FOR LIVER DISEASE
#4631Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing
#4632Drug for preventing and/or treating polycystic kidney disease
#4633PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATION
#46345,6-DIHETE LACTONE FOR TREATMENT OF MICROVASCULAR DYSFUNCTION
#4635SOTALOL HYDROCHLORIDE DOSING
#4636Conditioning irradiated tissue for increasing vascularity
#4637Improved Lyophilized Formulations Involving Hyaluronic Acid and Plasmatic Proteins, and Uses Thereof
#4638COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
#4639GBD-SSTad-SSTad recombinant protein and method for producing and using same
#4640Oxabicycloheptane prodrugs
#4641AAV MUTANT THAT EFFICIENTLY INFECTS SUPPORTING CELLS
#4642FUNCTIONALIZED FULLERENE GEL TUMOR TREATMENT
#4643Antibody Compositions and Methods of Use Thereof
#4644High concentration immunoglobulin composition for pharmaceutical application
#4645METHODS OF TREATING TUMORS
#4646Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use
#4647TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
#4648COMPOSITIONS AND METHODS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE
#4649Formulations of terlipressin
#4650Modulators of complement activity
#4651STABLE FORMULATION OF CETRORELIX
#4652COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION, ALLERGIES AND ASTHMA, CONTAINING VERONICASTRUM SIBIRICUM L. PENNELL AS ACTIVE INGREDIENT, AND USE THEREOF
#4653AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#4654METHODS OF PREVENTATIVE THERAPY FOR POST-TRAUMATIC OSTEOARTHRITIS
#4655ANTI-AGING COMPOSITIONS AND USES THEREOF
#4656HYDROGEN SULFIDE RELEASING POLYMER COMPOUNDS
#4657REDUCED NICOTINAMIDERIBOSIDES FOR TREATING/PREVENTING SKELETAL MUSCLE DISEASE
#4658Combination therapy effective against microorganisms, including drug resistant microorganisms
#4659INTERMITTENT DOSING OF MDM2 INHIBITOR
#4660CIPROFLOXACIN OTIC COMPOSITION AND KITS AND METHOD FOR USING SAME
#4661INJECTABLE SOLUTION OF NOREPINEPHRINE
#4662ANALYSIS OF MATERIALS FOR TISSUE DELIVERY
#4663METHODS OF ISOLATION AND USE OF CD39 STROMAL STEM CELLS
#4664INJECTABLE OFF-THE- SHELF CARTILAGE, TENDON, AND LIGAMENT REPAIR COMPOSITIONS AND METHODS OF USE
#4665ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS
#4666PHARMACEUTICAL FORMULATIONS CONTAINING CD80 EXTRACELLULAR DOMAIN-FC FUSION PROTEINS
#4667QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF
#4668HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#4669Conjugates of quaternized tubulysin compounds
#4670THE USE OF LOW MOLECULAR WEIGHT POLYVINYLPYRROLIDONE (PVP) TO REDUCE VISCOSITY OF HIGH CONCENTRATION PROTEIN FORMULATIONS
#4671SONOSENSITIZATION
#4672THERAPEUTIC SIRP-ALPHA ANTIBODIES
#4673Nucleoside-modified RNA for inducing an adaptive immune response
#4674NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION
#4675FORMULATIONS OF FOSAPREPITANT AND APREPITANT
#4676COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
#4677Method to Identify Responders to Osteoarthritis Therapeutics
#4678METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#4679Method of treating prostate cancer with GnRH antagonist
#4680METHOD OF PRESERVING CELLS FOR THERAPEUTIC USE
#4681Ethanol hardener and use thereof
#4682Pharmaceutical Composition for Alzheimer's Disease
#4683Accelerated treatment of COVID-19 and SAR's type viruses
#4684PROCASPASE-3 ACTIVATION AND IMMUNOTHERAPY FOR TREATMENT OF CANCER
#4685Parenteral unit dosage form of dihydroergotamine
#4686COMPOSITION FOR CASPASE INHIBITOR PRODRUG INJECTION
#4687Neuroquiescence—a treatment for neurodevelopmental and neurodegenerative bioelectrical dysregulation and demyelination
#4688Storage stable sincalide formulations
#4689METHODS AND COMPOSITIONS RELATING TO EMULSIONS COMPRISING FISH OIL AND/OR OMEGA-3 FATTY ACIDS
#4690Injectable composition containing prodrug of caspase inhibitors, and preparation method therefor
#4691Humanized BCMA antibody and BCMA-CAR-T cells
#4692Compositions for treatment of vascular disease
#4693Coronavirus vaccine
#4694METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#4695METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#4696COMPOSITION FOR REDUCING BODY FAT COMPRISING GREEN TEA EXTRACT CONTAINING GALLOCATECHIN GALLATE AS AN ACTIVE INGREDIENT AND MANUFACTURING METHOD THEREOF
#4697METHODS OF ENHANCING THE POTENCY OF INCRETIN-BASED DRUGS IN SUBJECTS IN NEED THEREOF
#4698Methods and compositions for treating undesired implanted tissue filler
#4699Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers
#4700Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers
#4701APPLICATION OF TEGASEROD IN PREPARATION OF ANTI-TUMOR DRUG
#4702Sensorineural Hair Cell Differentiation
#4703METHOD FOR INDUCING MASS APOPTOSIS OF CANCER CELLS BY ENHANCING THE OVERALL ACIDITY IN THE TUMOR
#4704IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES
#4705INJECTABLE POLYMER NANOPARTICLE COMPOSITIONS OF ANTITHROMBOTIC AGENTS AND METHODS THEREOF
#4706KRAS mutant protein inhibitors
#4707Composition of radioactive and non-radioactive microparticles
#4708MOMP telonanoparticles, and related compositions, methods and systems
#4709ANTIBODY-DRUG CONJUGATES WITH IMMUNE-MEDIATED THERAPY AGENTS
#4710Composition for treating and/or preventing Hepatitis B virus infection and the use thereof
#4711LIVE ATTENUATED INFLUENZA VACCINE COMPOSITION AND PROCESS FOR PREPARATION THEREOF
#4712HAPTOGLOBIN FOR USE IN TREATING AN ADVERSE SECONDARY NEUROLOGICAL OUTCOME FOLLOWING A HAEMORRHAGIC STROKE
#4713THERAPEUTIC METHODS AND COMPOSITIONS UTILIZING STROMAL VASCULAR FRACTION DERIVED FROM ADIPOSE TISSUE
#4714Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease
#4715PHARMACEUTICAL COMPOSITIONS COMPRISING AMIDE DERIVATIVES OF HYALURONIC ACID, FOR USE IN THE TREATMENT OF BONE TRAUMAS, IN PARTICULAR OF PATIENTS WITH PROBLEMS OF OSTEOPENIA OR OSTEOPOROSIS
#4716Compositions and products for infectious or inflammatory diseases or conditions
#4717Antiviral prodrugs and nanoformulations thereof
#4718COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTICS
#4719Stable, ready to use aqueous pharmaceutical composition of pemetrexed
#4720Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#4721Methods of treating lung cancer with CYP3A4 substrate drugs
#4722ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
#4723Stable aqueous capsaicin injectable formulations and medical uses thereof
#4724Maximizing Distribution and Minimizing Washout of Injectates in Bone and Method for Enhanced Aspirate Extraction
#4725Adrenaline pharmaceutical solution for an injection device
#4726Reduction of flake-like aggregation in nanoparticulate active agent compositions
#4727INJECTABLE TRIAMCINOLONE FORMULATIONS
#4728Extended release of neuregulin for treating heart failure
#4729Platform for generating safe cell therapeutics
#4730ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF
#4731Anti-NPR1 antibodies and uses thereof
#4732Extended local release of anti-CSFR1 antibodies
#4733Production of Biosimilar Ustekinumab In CHO Cells
#4734Prodrugs of a CDK inhibitor for treating cancers
#4735METHODS OF PREVENTING METHIONINE OXIDATION IN IMMUNOCONJUGATES
#4736METHODS FOR REDUCING TOXICITY OF A CHEMOTHERAPEUTIC DRUG
#4737BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#4738Novel Formulations Which Stabilize Low Dose Antibody Compositions
#4739RESPIRATORY VIRUS NUCLEIC ACID VACCINES
#4740Recombinant influenza viruses with stabilized HA for replication in eggs
#4741Compositions and treatments for
#4742Toxoplasma gondii vaccines and their use
#4743CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS
#4744METHODS OF TREATING MUSCULOSKELETAL DEFORMITIES IN QUADRUPED ANIMALS
#4745SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF
#4746COMPOSITION FOR PREVENTING OR TREATING NEUROTROPHIC KERATITIS WHICH CONTAINS PACAP PEPTIDE OR STABILIZED PACAP PEPTIDE
#4747COMBINED PHARMACEUTICAL COMPOSITION
#4748BIODEGRADABLE POLYESTERAMIDE USED FOR THE TREATMENT OF ARTHRITIC DISORDERS
#4749INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF
#4750Ganaxolone for use in treatment of status epilepticus
#4751Pharmaceutical compositions of testosterone
#4752METHODS FOR PREVENTING TOXICITY OF PLATINUM DRUGS
#4753Amorphous solid dispersions
#4754METHODS AND COMPOSITIONS FOR TREATING GASTRIC ULCERS
#4755METHOD OF DELIVERY OF INTRAVENOUS BACLOFEN
#4756Methods of treatment of temozolomide-resistant glioma using coenzyme Q10
#4757PROTEIN NANO- OR MICROPARTICLES AS ARTIFICIAL INCLUSION BODIES
#4758HYDROGEL COMPOSITIONS COMPRISING ENCAPSULATED CELLS AND METHODS OF USE THEREOF
#4759Treatment of Diabetes Mellitus by Long-Acting Formulations of Insulins
#4760Guiding musculoskeletal procedures
#4761COMPOSITIONS AND METHODS TO PROMOTE WOUND HEALING
#4762Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector
#4763Anti-TNF Antibodies, Compositions, and Methods for the Treatment of Active Ankylosing Spondylitis
#4764SUMO PEPTIDES FOR TREATING NEURODEGENERATIVE DISEASES
#4765NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
#476618F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
#4767INTRATHECAL AND INTRAVENOUS COMBINATION GENE THERAPY FOR THE TREATMENT OF INFANTILE BATTEN DISEASE
#4768Coronavirus vaccine
#4769NUCLEIC ACID VACCINES
#4770METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING SLIT2
#4771COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE
#4772COMPOSITIONS COMPRISING STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS AND USES THEREOF TO TREAT NEUROLOGICAL DISEASE
#4773Methods of Expanding Tumor Infiltrating Lymphocytes Using Engineered Cytokine Receptor Pairs and Uses Thereof
#4774A COMPOSITION, A KIT AND USE THEREOF
#4775Combination therapy
#4776THERAPEUTIC DRUG FOR DYSKINESIA
#4777PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#4778Nitroxyl donors with improved therapeutic index
#4779Method of treating tumours
#4780CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION
#4781VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES
#4782ANTIBODY FOR ANTI-CLAUDIN 18A2 AND USE THEREOF
#4783Resveratrol derivative and anti-fibrotic method using the same
#4784Peptide drug improvement using vitamin Band Haptocorrin binding substrate conjugates
#4785NOVEL FORMULATIONS
#4786METHODS FOR SAFE AND EFFECTIVE THROMBOLYSIS USING SEQUENTIAL ADMINISTRATION OF TISSUE PLASMINOGEN ACTIVATOR AND MUTANT PRO-UROKINASE
#4787Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by Paramyxoviridae
#4788AMNIOTIC FLUID FORMULATION FOR TREATMENT OF JOINT PAIN OR DISORDERS
#4789PHARMACEUTICAL COMPOSITION INJECTABLE INTO URINARY TRACT ORGAN CAVITY FOR PREVENTION OR TREATMENT OF UROTHELIAL CANCER
#4790Antibiotic combination therapies
#4791TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS
#4792Use of chlorogenic acid in preparation of drug for preventing and treating ocular inflammation
#4793CARRIER-BINDING AGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#4794METHOD FOR PREPARING BIOCOMPATIBLE POLYMER-BASED APIXABAN-LOADED MICROSPHERES
#4795NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#4796Platform for generating safe cell therapeutics
#4797METHOD FOR DEACETYLATION OF BIOPOLYMERS
#4798USE OF THE IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVIATING SYMPTOMS OF PULMONARY SARCOIDOSIS
#4799T-cell modulatory multimeric polypeptides and methods of use thereof
#4800pH-RESPONSIVE SILICA METAL ORGANIC FRAMEWORK NANOPARTICLES FOR DELIVERY OF BIOACTIVE MOLECULES